Eaton Vance Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.33M | Hold |
|
|||||
|
2022
Q2 | $1.24M | Sell |
|
|||||
|
2022
Q1 | $1.35M | Sell |
|
|||||
|
2021
Q4 | $1.64M | Buy |
|
|||||
|
2021
Q3 | $2.29M | Buy |
|
|||||
|
2021
Q2 | $3.47M | Buy |
|
|||||
|
2021
Q1 | $2.49M | Hold |
|
|||||
|
2020
Q4 | $3.13M | Hold |
|
|||||
|
2020
Q3 | $1.71M | Hold |
|
|||||
|
2020
Q2 | $1.5M | Hold |
|
|||||
|
2020
Q1 | $866K | Hold |
|
|||||
|
2019
Q4 | $1.24M | Hold |
|
|||||
|
2019
Q3 | $837K | Hold |
|
|||||
|
2019
Q2 | $961K | Hold |
|
|||||
|
2019
Q1 | $729K | Hold |
|
|||||
|
2018
Q4 | $583K | Hold |
|
|||||
|
2018
Q3 | $905K | Hold |
|
|||||
|
2018
Q2 | $1.2M | Buy |
|